Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
about
Pharmacotherapy and airway remodelling in asthma?Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysisRecent advances in the management of asthma using leukotriene modifiersEmerging role of antileukotriene therapy in allergic rhinitisSerine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway diseaseAllergic rhinitis and asthma: inflammation in a one-airway condition.Fortnightly review: modern drug treatment of chronic asthma.Alternative strategies in the treatment of bronchial asthma.Novel therapy for asthma.Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.Antileukotrienes in asthma: present situation.The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.An update of the leukotriene modulators for the treatment of asthma.Inflammatory basis of exercise-induced bronchoconstrictionCysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonistsRegulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.Hemopoietic progenitors: the role of eosinophil/basophil progenitors in allergic airway inflammation.Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics.Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells.A Tale of Two CysLTs.A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.Leukotriene D4 induces chemotaxis in human eosinophilc cell line, EoL-1 cells via CysLT1 receptor activation.Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma.Impact of the genetic variants of GLCCI1 on clinical features of asthmatic patients.The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin-5 deficiency.Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice.Role of genetic variations of chitinase 3-like 1 in bronchial asthmatic patients.
P2860
Q24678822-A180513F-F117-4CFA-AF18-B9C36F798C3AQ26782714-38517EB7-E1CA-4931-8109-10BCB404FA04Q28166742-92D30D31-DE81-4A3B-9556-B74C6D4974A6Q28191844-DDD82B9E-3FBE-4E34-9ADB-317FE85C9B7FQ31075878-E464DEBA-2D98-4C09-AD0A-84DA9D54E7F4Q33265229-BBEB4FA0-4034-406B-A012-BBD476853BBAQ33793696-AB337249-CD6F-4509-880A-1D34928A207EQ33801225-591AB6AA-F99E-42A8-A46F-5B8FDE2EDAB3Q34074657-9F6BDF79-E481-45C9-9EBA-21F0F138EBBBQ34240729-1DB75997-A116-492F-8794-751C002520DAQ34240893-34F5CE98-F678-4019-9CEB-45C521869EBEQ34291204-BDAAFF6C-492B-401B-8A2A-8E7683D01DF0Q34823193-AE7A7725-E178-4AEA-B97F-900E36C03360Q35779312-0E03F1F7-C909-4A3C-BA64-7C766AA0812BQ35814442-2C1A9617-EA12-4E79-B862-129B7BC9929BQ36091759-C3397915-3451-4F07-9B34-74629D6304D0Q36370341-960C697A-6212-4EF4-9AA3-2FEA179328B9Q41370706-7E645C66-2245-4A75-AFE8-BB3F2B4BCDCEQ43061567-B12A5234-6DF3-40D5-B9EC-BA8DC2615D9DQ43546448-874C1A29-9529-4900-9B65-F5ECD8450922Q43650613-0F8B767D-3B01-48BE-98D4-1B1AEB901CE1Q43790347-17385DFE-1DEC-4A72-A1C3-643CF7DB628AQ43846995-C90AD0E5-FAB8-43A0-9696-313B90F72875Q44248031-0B37F1E9-4CB8-4472-9CA7-DF4D8FA107D7Q46642193-951A514D-B7B4-42FD-A4EC-39868E912D5FQ47139569-CE800763-17E5-48B5-8D3B-EAC47C649A86Q51556201-9BD117F3-007A-4E1B-8536-6C5D4431EE81Q52771825-DFEB027E-223A-44BA-BC87-C412BF9561D6Q53541065-70F3208F-631B-40ED-A869-32505EFD0B0AQ54083839-36431B9F-4F16-4A47-93C4-B748B8C0F56CQ55077184-91425FC4-7081-47B3-9A66-20F1ACA737A9
P2860
Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Effect of the leukotriene rece ...... ucosa of patients with asthma.
@ast
Effect of the leukotriene rece ...... ucosa of patients with asthma.
@en
type
label
Effect of the leukotriene rece ...... ucosa of patients with asthma.
@ast
Effect of the leukotriene rece ...... ucosa of patients with asthma.
@en
prefLabel
Effect of the leukotriene rece ...... ucosa of patients with asthma.
@ast
Effect of the leukotriene rece ...... ucosa of patients with asthma.
@en
P2093
P2860
P356
P1433
P1476
Effect of the leukotriene rece ...... ucosa of patients with asthma.
@en
P2093
P2860
P304
P356
10.1136/THX.53.10.835
P407
P577
1998-10-01T00:00:00Z